Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial
Year: 2011
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet
Authors: Sube Banerjee, Jennifer Hellier, Michael Dewey, Renee Romeo, Clive Ballard, Robert Baldwin, Peter Bentham, Chris Fox, Clive Holmes, Cornelius Katona, Martin Knapp, Claire Lawton, James Lindesay, Gill Livingston, Niall McCrae, Esme Moniz-Cook, Joanna Murray, Shirley Nurock, Martin Orrell, John O'Brien, Michaela Poppe, Alan Thomas, Rebecca Walwyn, Kenneth Wilson, Alistair Burns
Institutions: King's College London, University of Manchester, University of Birmingham, University of East Anglia, University of Southampton, University College London, University of Cambridge, University of Leicester, Hull York Medical School, Alzheimer's Society, Newcastle University, University of Liverpool
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Keywords: sertraline, mirtazapine, antidepressants, Alzheimer's disease, treatment efficacy, adverse events, older adults, Cornell Scale for Depression in Dementia, anticholinergic effects, serotonin reuptake inhibitors, atypical antidepressants, caregivers, long-term outcomes, health technology assessment, cost-effectiveness, quality of life
Open Access status: green
Award: G2470312857
OpenAlex ID: W2145846347
